• β-Elemene Suppresses Adipogenesis via AMPK Pathway in 3T3-L1

  2026-07-13

  This study demonstrates that β-Elemene inhibits adipogenesis in 3T3-L1 preadipocytes by activating the AMPK pathway, counteracting insulin resistance-induced lipid accumulation. The findings support β-Elemene's utility as a mechanistic probe in metabolic and obesity research workflows.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-07-13

  This study elucidates a pyroptosis-independent function for Gasdermin C (GSDMC) in pancreatic ductal adenocarcinoma (PDAC), showing that GSDMC enhances stemness and immune evasion by regulating gene expression from the nucleus. The findings reveal new molecular mechanisms and highlight GSDMC as a promising therapeutic target for overcoming resistance in aggressive PDAC.

• Ivermectin (SKU A2813): Reliable Solutions for Anti-Parasiti

  2026-07-12

  This scenario-driven guide demonstrates how Ivermectin (SKU A2813) meets the reproducibility, quality, and workflow challenges commonly encountered in anti-parasitic and cell viability research. Drawing on both product specifications and peer-reviewed findings, the article provides practical answers to real laboratory questions, positioning Ivermectin as a trusted anti-parasitic research compound for biomedical scientists.

• Isorhamnetin Promotes Oocyte Maturation via PI3K/Akt Activat

  2026-07-10

  The reference study demonstrates that isorhamnetin, a dietary flavonoid, promotes oocyte maturation by activating the PI3K/Akt pathway while reducing oxidative and endoplasmic reticulum stress. These findings provide mechanistic insight into improving in vitro oocyte quality and offer a foundation for potential infertility interventions.

• Ivermectin as a Broad-Spectrum Anti-Parasitic: Applied Workf

  2026-07-09

  Leverage Ivermectin's high-purity, broad-spectrum anti-parasitic properties to streamline parasitology drug development and advanced research. This guide delivers actionable workflow optimizations, troubleshooting tips, and integrates innovations from tumor biology to inspire next-generation assay design.

• Forskolin: Strategic Adenylate Cyclase Activation in Transla

  2026-07-09

  This thought-leadership article unpacks Forskolin’s mechanistic role as a direct adenylate cyclase activator, providing actionable guidance for translational researchers across stem cell, inflammation, and epithelial disease models. Integrating new mechanistic evidence and comparative findings, it positions APExBIO’s Forskolin as a strategic tool for bridging cellular insights to clinical translation.

• Proteinase K: Unraveling Enzymatic Precision in DNA Integrit

  2026-07-08

  Explore how Proteinase K, a broad-spectrum serine protease, enables uncompromising DNA integrity and contaminant removal across challenging molecular biology workflows. This article provides advanced insight into mechanistic action, optimal usage, and new findings in fungal vesicle research.

• Imipenem in Translational Research: Mechanistic Insight to S

  2026-07-08

  Explore the strategic and mechanistic roles of imipenem, a semisynthetic thienamycin antibiotic, in translational antibacterial research. This article connects molecular mechanisms, experimental guidance, resistance trends, and future perspectives—empowering researchers to optimize protocols and address evolving multidrug resistance using APExBIO’s imipenem.

• Firefly Luciferase mRNA: Optimizing Reporter Workflows & Del

  2026-07-07

  Firefly Luciferase mRNA (ARCA, 5-moUTP) from APExBIO sets a new standard for bioluminescent assays, combining advanced capping and nucleotide modification for robust signal and stability. Explore protocols, troubleshooting, and innovations that enhance gene expression and in vivo imaging with data-driven, bench-ready guidance.

• D-Luciferin: Optimizing Firefly Luciferase Substrate Workflo

  2026-07-07

  D-Luciferin empowers ultrasensitive bioluminescence imaging, enabling precise quantification of tumor burden, gene expression, and pharmacodynamics in living models. This article delivers protocol enhancements, troubleshooting strategies, and real-world workflow tips for maximizing the impact of this gold-standard firefly luciferase substrate in translational cancer research.

• IDH2-Mediated Metabolic Reprogramming Drives CRC Progression

  2026-07-06

  This article examines how elevated IDH2 expression in colorectal cancer (CRC) orchestrates metabolic reprogramming, promoting tumor growth through modulation of α-ketoglutarate dynamics and HIF-1α signaling. These mechanistic insights highlight metabolic vulnerabilities and inform research strategies targeting the hypoxia signaling pathway in CRC.

• Tunable Human Intestinal Organoids: Balancing Renewal and Di

  2026-07-06

  This study establishes a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation. By modulating key signaling pathways with small molecules, the authors enable enhanced cellular diversity and proliferation in organoid cultures, offering broad implications for high-throughput research and disease modeling.

• Angiotensin II–HIF-1α-HILPDA Axis Suppresses Ferroptosis in

  2026-07-05

  This study reveals that local angiotensin II drives radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis through a positive feedback loop involving HIF-1α and HILPDA. The findings identify novel molecular targets for radiosensitization, suggesting that dual inhibition of Ang II signaling and induction of ferroptosis could improve NPC radiotherapy outcomes.

• Ivermectin: Broad-Spectrum Anti-Parasitic for Research Use

  2026-07-04

  Ivermectin is a validated, high-purity broad-spectrum anti-parasitic compound widely used in parasitology and translational research. Its action on parasite neuromuscular targets is well-characterized, and APExBIO provides rigorous analytical controls for reproducibility. Proper storage and handling are critical for experimental integrity.

• PD98059 (SKU A1663): MEK Inhibition for Reliable Cell Assays

  2026-07-03

  This article provides evidence-based, scenario-driven guidance for deploying PD98059 (SKU A1663) as a selective MEK inhibitor in cell viability, proliferation, and cytotoxicity assays. Emphasizing practical solutions to common experimental challenges, it details protocol optimization and data interpretation strategies backed by literature and supplier specifications. Researchers gain actionable insights on why PD98059 from APExBIO stands out for reproducibility and workflow efficiency.

16814 records 1/1121 page Next 12345 下5页 Last page